IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
23 hedge funds and large institutions have $9.16M invested in Interpace Biosciences, Inc. Common Stock in 2015 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
23
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$433K | |
| 2 | +$78K | |
| 3 | +$17K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.73K |
| 5 |
Bank of New York Mellon
New York
|
+$1.29K |
Top Sellers
| 1 | -$119K | |
| 2 | -$43K | |
| 3 | -$27.2K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$5K |
| 5 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
-$3.58K |